ZAI Lab Competitors and Similar CompaniesClear all

ZAI Lab's competitors and similar companies include Amoy Diagnostics, BGI Genomics, Berry Genomics and Shanghai Junshi Biosciences.
ZAI Lab
ZAI Lab
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
Amoy Diagnostics
Amoy Diagnostics
Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine.
BGI Genomics
BGI Genomics
BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.
Berry Genomics
Berry Genomics
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date
Founding Date
2014
Founding Date
2008
Founding Date
1999
Founding Date
2010
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
CN HQ
Suzhou, CN
Hong Kong, HK
Taipei, TW
Cambridge, US
Menlo Park, US
Locations
Xiamen, CN HQ
Singapore, SG
Locations
Shenzhen, CN HQ
Brisbane, AU
Copenhagen, DK
Addis Ababa, ET
Hong Kong, HK
Budapest, HU
Kobe, JP
see more
Locations
CN HQ
Locations
Shanghai, CN HQ
Employees
Employees
1,869
Employees
1,144
Employees
3,702
Employees
1,4023% decrease
Employees
2,568
Valuation ($)
Valuation ($)
3.2 b
Valuation ($)
1.3 b
Valuation ($)
2.7 b
Valuation ($)
460.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$399m (FY, 2024)
Revenue (est.)
¥1.1b (FY, 2024)
Revenue (est.)
¥3.8b (FY, 2024)
Revenue (est.)
¥1.1b (FY, 2023)
Revenue (est.)
¥1.9b (FY, 2024)
Cost of goods
Cost of goods
$147.1m (FY, 2024)
Cost of goods
¥169.1m (FY, 2024)
Cost of goods
¥2.3b (FY, 2024)
Cost of goods
¥636.2m (FY, 2023)
Cost of goods
¥410.7m (FY, 2024)
Gross profit
Gross profit
$251.9m (FY, 2024)
Gross profit
¥934.8m (FY, 2024)
Gross profit
¥1.6b (FY, 2024)
Gross profit
¥506.6m (FY, 2023)
Gross profit
¥1.5b (FY, 2024)
Net income
Net income
($257.1m) (FY, 2024)
Net income
¥254.9m (FY, 2024)
Net income
(¥912.1m) (FY, 2024)
Net income
(¥425.3m) (FY, 2023)
Net income
(¥1.4b) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 985m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 145.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Amoy Diagnostics
HQ
Xiamen, CN
Employees
1,144

Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine.

View company
BGI Genomics
HQ
Shenzhen, CN
Employees
3,702

BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.

View company
Berry Genomics
HQ
CN
Employees
1,402↓ 3% decrease

Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing.

View company
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,568

Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.

View company